Barragán Questions FDA Office Cuts Amid 2026 Cyclosporiasis Surge and NIH Funding Reductions
The segment shows Rep. Nanette Barragán (D-CA) questioning witness Mr. Boykin during a House hearing on biomedical innovation and the FDA's role. She displays a July 2025 FDA organizational chart noting eliminated offices including food oversight, references a cyclosporiasis outbreak, and cites a New York Times article on FDA collapse. Barragán quotes Boykin's July 22, 2025 article on risks from NIH cuts, hostility to international students, and attacks on universities, then asks about tariffs on pharmaceuticals. Boykin affirms the need for robust, experienced FDA staffing, NIH basic research funding, and an attractive environment for global talent. The clip ends with the chair recognizing the next member.
Source: Forbes Breaking News